A Report for ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share

Filing Manager: Novo Holdings A/S
Reporting Manager: Novo Holdings A/S
Security: ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share
Shares outstanding: 38.2M shares
Disclosed Ownership: 1.87M shares
Ownership: 4.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 16:59:38 UTC
Date of event: 30 Jun 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Novo Holdings A/S	4.9%	1.87M	1.87M	0	Barbara Fiorini	Barbara Fiorini, General Counsel, Finance & Operations